Bioengineering Bacteria for Drug Delivery
Osel (http://www.oselinc.com/) in Santa Clara, CA, works in the emerging field of bacterial therapeutics, focusing on the development of live bacterial products for the prevention and treatment of urogenital and gastrointestinal diseases.
The term bacterial therapeutics distinguishes Osel’s approach from probiotics. “People think of probiotics as health-food store products,” says co-founder Peter P. Lee, M.D., an immunologist at Stanford University and acting CEO at Osel. “We apply a tremendous amount of science to our products and want to shift the mindset.”
Osel’s newest product uses a bio-engineered bacterium that lives in the vaginal tract of healthy women to deliver a potent drug to block HIV. “It’s a novel way to think about drug delivery,” Dr. Lee says.
Dr. Lee co-founded Osel in 1998 with Gary Schoolnik, M.D., an infectious disease expert at Stanford University; David Ho, M.D., director of the Aaron Diamond AIDS Research Center in New York City; and Peter Kim, Ph.D., president of Merck Research Laboratory in West Point, PA.
By creating a bacteria that could help aid in blocking HIV, urogenital and gastrointestinal diseases. By further supporting this research, it can help prevent HIV or even treat it as further research goes. Since thousands of people are vulnerable to HIV, by stopping or preventing the spread or even the interaction with it, it can help succumb the development of AIDS and aid thousands of humans.
Source:http://www.genengnews.com/articles/chitem.aspx?aid=2011&chid=0
-Perryl Libardo
section 501
The term bacterial therapeutics distinguishes Osel’s approach from probiotics. “People think of probiotics as health-food store products,” says co-founder Peter P. Lee, M.D., an immunologist at Stanford University and acting CEO at Osel. “We apply a tremendous amount of science to our products and want to shift the mindset.”
Osel’s newest product uses a bio-engineered bacterium that lives in the vaginal tract of healthy women to deliver a potent drug to block HIV. “It’s a novel way to think about drug delivery,” Dr. Lee says.
Dr. Lee co-founded Osel in 1998 with Gary Schoolnik, M.D., an infectious disease expert at Stanford University; David Ho, M.D., director of the Aaron Diamond AIDS Research Center in New York City; and Peter Kim, Ph.D., president of Merck Research Laboratory in West Point, PA.
By creating a bacteria that could help aid in blocking HIV, urogenital and gastrointestinal diseases. By further supporting this research, it can help prevent HIV or even treat it as further research goes. Since thousands of people are vulnerable to HIV, by stopping or preventing the spread or even the interaction with it, it can help succumb the development of AIDS and aid thousands of humans.
Source:http://www.genengnews.com/articles/chitem.aspx?aid=2011&chid=0
-Perryl Libardo
section 501
posted by Pendragon (Perryl Libardo) at 11:24 AM
0 Comments:
Post a Comment
<< Home